Alcon
Alcon is a leading global company in the vision care sector, headquartered in Geneva, Switzerland. Established in 1945, it specializes in developing and manufacturing innovative medical devices and pharmaceuticals focused on eye care. The company operates in two primary segments: Vision Care and Surgical. The Vision Care segment offers a range of products, including contact lenses and ocular health solutions, with well-known brands such as Dailies, Total1, and Air Optix, capturing a significant share of the U.S. contact lens market. The Surgical segment provides essential tools and devices for ophthalmic surgeries, including intraocular lenses and advanced surgical equipment like the Centurion phacoemulsification device used in cataract procedures. After operating as a subsidiary of Novartis for nine years, Alcon became an independent public company in April 2019, continuing its commitment to delivering comprehensive eye care solutions.
LENSAR
Acquisition in 2025
LENSAR, Inc. is a commercial-stage medical device company based in Orlando, Florida, established in 2004. It specializes in the design, development, and marketing of advanced femtosecond laser systems aimed at improving cataract surgery outcomes. The company's flagship product, the LENSAR Laser with Streamline IV, enhances the precision and efficiency of refractive cataract surgery by incorporating advanced features such as superior imaging capabilities and customizable treatment planning. This system assists surgeons in managing astigmatism and optimizing refractive results through innovative technology like the proprietary Augmented Reality™ 3-D model and the IntelliAxis Refractive Capsulorhexis® feature. These advancements facilitate accurate toric intraocular lens alignment and streamline surgical workflows, ultimately improving patient outcomes. LENSAR continues to expand its platform's capabilities, enabling the treatment of additional corneal conditions and enhancing the overall surgical experience for both patients and surgeons.
BELKIN Vision
Acquisition in 2024
BELKIN Vision focuses on developing a laser device that aids healthcare professionals in the treatment of glaucoma. The company's technology offers a non-invasive, non-contact, instantaneous, painless, and automated approach to laser therapy. By promoting accessibility to first-line drop-less glaucoma care, BELKIN Vision enables any ophthalmologist to effectively treat patients. This innovation aims to enhance treatment outcomes and improve the overall quality of care for individuals suffering from glaucoma.
LensX Lasers
Acquisition in 2010
LensX Lasers is a developer of surgical lasers used for the reparation of cataracts.
Wavelight
Acquisition in 2007
Wavelight designs, manufactures and markets innovative laser systems for a range of medical, aesthetic and industrial applications. Medical applications include ophthalmology, dermatology and urology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.